E-LIB Suche - Ergebnisse für: Cheraghali, Abdol Majid

1

Identifying Factors Affecting the Pharmaceutical Supply Cha..:

Esmaeillou, Yaser ; Masoudi Asl, Iravan ; Tabibi, Seyed Jamalleddin.
Galen Medical Journal. 6 (2023) 4 - p. , 2023

2

Clinical efficacy of convalescent plasma for treatment of C..:

Abolghasemi, Hassan ; Eshghi, Peyman ; Cheraghali, Abdol Majid...
Transfusion and Apheresis Science. 59 (2020) 5 - p. 102875 , 2020

Link: https://doi.org/10.1016/..

3

A system dynamics model for national drug policy:

Abdollahiasl, Akbar ; Kebriaeezadeh, Abbas ; Dinarvand, Rassoul...
DARU Journal of Pharmaceutical Sciences. 22 (2014) 1 - p. , 2014

Link: https://doi.org/10.1186/..

4

Evaluation of heavy metals contamination in Iranian foodstu..:

Hadiani, Mohammad Rasoul ; Farhangi, Roqieh ; Soleimani, Homeira..
Food Additives & Contaminants: Part B. 7 (2013) 1 - p. 74-78 , 2013

Link: https://doi.org/10.1080/..

5

Impacts of international sanctions on Iranian pharmaceutica..:

Cheraghali, Abdol Majid
DARU Journal of Pharmaceutical Sciences. 21 (2013) 1 - p. , 2013

Link: https://doi.org/10.1186/..

6

Biosimilars; a unique opportunity for Iran national health ..:

Cheraghali, Abdol Majid
DARU Journal of Pharmaceutical Sciences. 20 (2012) 1 - p. , 2012

Link: https://doi.org/10.1186/..

7

Cost Assessment of Implementation of Immune Tolerance Induc..:

Cheraghali, Abdol Majid ; Eshghi, Peyman
Value in Health Regional Issues. 1 (2012) 1 - p. 54-58 , 2012

Link: https://doi.org/10.1016/..

8

Scientific Apartheid:

Cheraghali, Abdol Majid
Hepatitis Monthly. 12 (2012) 3 - p. 158-159 , 2012

Link: https://doi.org/10.5812/..

9

Cost effectiveness of Iran national plasma contract fractio..:

Cheraghali, Abdol Majid
DARU Journal of Pharmaceutical Sciences. 20 (2012) 1 - p. , 2012

Link: https://doi.org/10.1186/..

10

Implications of Confidential Unit Exclusion in Providing Su..:

Cheraghali, Abdol Majid
Hepatitis Monthly. 11 (2011) 11 - p. 877-879 , 2011

Link: https://doi.org/10.5812/..

11

Improving availability and affordability of plasma-derived ..:

Cheraghali, Abdol Majid ; Abolghasemi, Hassan
Biologicals. 38 (2010) 1 - p. 81-86 , 2010

Link: https://doi.org/10.1016/..

12

Evaluating Antibiotics Administration's Pattern and Its Fin..:

Esmaeil Soufian, Pouria ; Bagheri, Mahdi ; Cheraghali, Abdol Majid
http://journals.sbmu.ac.ir/index.php/ijps/article/view/40245/30034. , 2021

Link: http://journals.sbmu.ac...

13

Gentamicin-Loaded Chitosan Nanoparticles Improve Its Therap..:

Razei, Ali ; Cheraghali, Abdol Majid ; Saadati, Mojtaba...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344153/. , 2019

Link: http://www.ncbi.nlm.nih...

14

Evaluation of prescriptions of medicines not included in Ir..:

Zargaran, Marzieh ; Nikfar, Shekoufeh ; Cheraghali, Abdol Majid
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084479/. , 2016

Link: http://www.ncbi.nlm.nih...

15

Comparison of Bypassing Agents in Bleeding Reduction in Tre..:

Golestani, Mina ; Eshghi, Peyman ; Rasekh, Hamid Reza...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...